cytarabine has been researched along with Emesis in 75 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 36 (48.00) | 18.7374 |
| 1990's | 17 (22.67) | 18.2507 |
| 2000's | 7 (9.33) | 29.6817 |
| 2010's | 12 (16.00) | 24.3611 |
| 2020's | 3 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahern, K; Correia De Farias, M; Pham, J; Sanderson, R; Walsh, K | 1 |
| Bonizzoni, E; Cascavilla, N; Celio, L; Dargenio, M; Di Renzo, N; Greco, G; Mannina, D; Matera, R; Mazza, P; Melillo, L; Merenda, A; Musso, M; Pastore, D; Pavone, V; Porretto, F | 1 |
| Lertvivatpong, N; Monsereenusorn, C; Photia, A; Rujkijyanont, P; Ruktrirong, J; Traivaree, C | 1 |
| Andrick, B; Clemmons, AB; DeRemer, D; Gandhi, A; Orr, J; Sportes, C | 1 |
| Gwak, HS; Han, JY; Joo, J; Kim, HT; Kim, S; Lee, JS; Lee, SH; Shin, SH; Yoo, H | 1 |
| Adès, L; Ame, S; Beyne-Rauzy, O; Braun, T; Charbonnier, A; Delaunay, J; Dreyfus, F; Fenaux, P; Prebet, T; Raffoux, E; Stammatoullas, A; Vey, N; Wattel, E | 1 |
| He, H; Li, X; Li, XP; Li, Y; Liu, ZG; Liu, ZQ; Wang, Y; Xu, YJ; Yin, JY; Zhai, M; Zhang, Y; Zhou, F; Zhou, HH | 1 |
| Badar, T; Borthakur, G; Cortes, J; Ferrajoli, A; Garcia-Manero, G; Kadia, T; Kantarjian, H; Mattiuzzi, G; O'Brien, S; Poku, R; Wierda, W | 1 |
| Clark, SM; Clemmons, AB; DeRemer, DL; Garren, J; Kota, VK; Schaack, L | 1 |
| Díaz-Carrasco, MS; Espuny-Miró, A; Galera-Miñarro, A; Olmos-Jiménez, R; Pascual-Gazquez, JF | 1 |
| Apperley, JF; Auner, HW; Contento, A; Ellis, S; Giles, C; Kanfer, EJ; MacDonald, DH; Naresh, K; Pavlů, J; Rahemtulla, A; Szydlo, RM | 1 |
| Bekele, BN; Blamble, DA; Borthakur, G; Cabanillas, M; Cortes, JE; Kantarjian, H; Mattiuzzi, GN; O'Brien, S; Xiao, L | 1 |
| Barzal, J; Gawronski, K; Mlot, B; Oborska, S; Pielichowski, W; Rzepecki, P; Wasko-Grabowska, A | 1 |
| Goto, T; Ishibashi, M; Okamura, S; Tanimoto, K | 1 |
| D'Amore, ES; Finotto, S; Menin, A; Paolini, R; Pizzolo, G; Rodeghiero, F; Semenzato, G; Visco, C; Zaja, F; Zambello, R; Zanotti, R | 1 |
| Amadori, S; Avvisati, G; Baccarani, M; Cantore, N; Di Bona, E; Ferrara, F; Fioritoni, G; Gallo, E; Invernizzi, R; Lazzarino, M; Liso, V; Lo-Coco, F; Mandelli, F; Mariani, G; Petti, MC; Ricciuti, F; Selleri, C; Sica, S; Vegna, ML; Veneri, D | 1 |
| Guang, ZZ; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Lin, TY; Liu, DG; Sun, XF; Xu, GC; Xu, RH; Zhang, L; Zhou, ZM | 1 |
| English, MW; Karandikar, SS; Sastry, J | 1 |
| Forcier, RJ; LeMarbre, PA; Maurer, LH; O'Donnell, JF; Quinn, BM; Stern, R | 1 |
| du Plessis, HE; Falkson, G; Falkson, HC; Meyer, TE | 1 |
| Glick, JH; Hines, JD; Keller, AM; Mazza, JJ; Oken, MM; Streeter, RR | 1 |
| Carpenter, J; Fishkin, E; Krauss, S; Moore, MR; Raab, S; Raney, M; Smalley, RV; Stagg, M; Velez-Garcia, E; Vogel, CL | 1 |
| Marie, JP; Pochat, L; Pommier, Y; Zittoun, RA | 1 |
| Altman, AJ; Dinndorf, P; Quinn, JJ | 1 |
| Chavez, CM; Duncan, MH; Holdsworth, MT; Leasure, MM; Raisch, DW | 1 |
| Baker, D; Fairclough, D; Mulhern, RK; Pui, CH; Relling, MV | 1 |
| Gondo, H; Harada, M; Matsuishi, H; Omori, F; Otsuka, T; Shibuya, T; Taniguchi, S; Teshima, T; Yamano, Y; Yamazaki, K | 1 |
| Fairclough, D; Longmire, W; Mulhern, RK; Relling, MV; Tyc, VL; Ward, PM | 1 |
| Geissler, K; Gisslinger, H; Haas, OA; Huhmann, IM; Jäger, U; Kalhs, P; Knöbl, P; Korninger, L; Lechner, K; Mannhalter, C; Mitterbauer, G; Pabinger, I; Schwarzinger, I; Watzke, HH | 1 |
| Sundström, GM; Wahlin, A | 1 |
| Campbell, J; De La Serna, J; Diaz-Mediavilla, J; Francisco Tomás, J; García de Paredes, ML; Grande, C; Solano, C | 1 |
| Chen, PM; Chiou, TJ; Fang, FS; Hsieh, RK; Liu, JH; Tung, SL; Tzeng, CH; Wang, WS; Yen, CC | 1 |
| Beran, M; Estey, E; Jeha, S; Kantarjian, H; Keating, M; O'Brien, S; Rios, MB; Vitek, L; Zurlo, MG | 1 |
| Miyata, Y; Saito, M; Takeyama, H; Yamada, H; Yamamoto, Y | 1 |
| Kanamaru, A; Miyawaki, S; Mizoguchi, H; Nakamura, T; Ohashi, Y; Ohno, R; Tomonaga, M; Tsukagoshi, S; Yoshida, S | 1 |
| Boerman, RH; Mattijssen, V; Mulder, AH; Raemaekers, JM | 1 |
| Belt, R; Coon, J; Cord, M; Dix, S; Geller, R; Howard, S | 1 |
| Klener, P; Procházka, B; Slabý, J; Trnený, M | 1 |
| Aiken, R; Akerley, W; Allen, J; Baidas, S; Batchelor, T; Bent, MJ; Campbell, T; Chamberlain, MC; Cohn, A; Fulton, D; Gertler, SZ; Gilbert, M; Glantz, MJ; Greenberg, HS; Gutheil, JC; Heros, D; Howell, SB; Jaeckle, KA; LaFollette, S; Lesser, G; Maria, B; Mason, W; Moots, P; New, P; O'Day, SJ; Phuphanich, S; Recht, L; Rogers, L; Russell, C; Shapiro, W; Swinnen, L; Wong, E | 1 |
| Guenther, PP; Huebner, A; Neumeister, V; Parwaresch, R; Sobottka, SB; Todt, H; Weissbach, G | 1 |
| Atlas, MP; Giugliano, DM; Mahan, RA; Parker, RI; Prakash, D | 1 |
| Bedwinek, J; Goldberg, RS; Joss, RA; Krakoff, IH; Yates, JW | 1 |
| Brenning, G; Engstedt, L; Franzén, S; Gahrton, G; Gullbring, B; Höglund, S; Holm, G; Jameson, S; Killander, A; Killander, D; Lockner, D; Mellstedt, H; Palmblad, J; Reizenstein, P; Skårberg, KO; Swedberg, B; Udén, AM; Wadman, B; Wide, L | 1 |
| Carden, PA; Ekert, H; Mitchell, SL; Tiedemann, K; Waters, KD | 1 |
| Atkins, JN; Craig, JB; Goldklang, GA; Jackson, DV; Muss, HB; Powell, BL; Richards, F; Schnell, FM; Stuart, RK; White, DR | 1 |
| Alvarado, C; Camitta, B; Fernbach, DJ; Krischer, J; Mahoney, DH; Tebbi, CK | 1 |
| Büchner, T; Diedrich, H; Donhuijsen-Ant, R; Gerith-Stolzenburg, S; Heil, G; Hiddemann, W; Ho, AD; Maschmeyer, G; Planker, M; Schumacher, K | 1 |
| Cleary, S; Howell, SB; Lucas, W; Markman, M; Weiss, R | 1 |
| Grunberg, SM | 1 |
| Booraem, CD; Flowers, JV; Gumbiner, J | 1 |
| Bishop, JF; Cobcroft, R; Dodds, A; Joshua, DE; Kronenberg, H; Lowenthal, RM; Manoharan, A; Whiteside, MG; Wolf, M | 1 |
| Cuttner, J; Dutcher, JP; Holland, JF; Paciucci, PA; Strauman, JJ; Wiernik, PH | 1 |
| Civin, CI; Krischer, J; Land, VJ; Ragab, AH; Steuber, CP; Vietti, TJ | 1 |
| Donnelly, H; Donner, AL; Fanucchi, M; Fox, J; Groshen, S; Leyland-Jones, B; Myskowski, P | 1 |
| Capizzi, RL; Craig, JB; Powell, BL; White, DR | 1 |
| Fibbe, WE; Kootte, AM; Lie, R; Peters, WG; Rodenburg, CJ; van Berkel, M; van Hennik, MB; Veltkamp, JJ; Willemze, R | 1 |
| Lie, SO; Slørdahl, S | 1 |
| Küchler, R; Kuse, R | 1 |
| Markman, M | 1 |
| Prentice, HG; Robbins, G; Wimperis, JZ | 1 |
| Band, PR; Bernard, J; Holland, JF; Rall, D; Walker, M; Weil, M | 1 |
| Avery, GB; Kraybill, EN; Movassaghi, N; Sever, JL | 1 |
| Andrews, NC; Davis, HL; Madden, R; Rochlin, DB; Sedransk, N; Weiss, AJ; Wilson, WL | 1 |
| Gunz, FW; Levi, JA; Vincent, PC | 1 |
| Bodey, GP; Bonnet, JD; Coltman, CA; Freireich, EJ; Gehan, EA; Haut, AB; Hewlett, JS; McCredit, KB; Saiki, JH; Wilson, HE | 1 |
| Armentrout, SA; Burns, CP | 1 |
| Burningham, R; Falkson, G; Gailani, S; Holland, JF; Larsen, V; Leone, L | 1 |
| Cohen, SM; Greenspan, EM; Weiner, MJ | 1 |
| Bateman, CJ; Crowther, D; Fairley, GH; Malpas, JS; Scott, RB; Vartan, CP; Whitehouse, JM | 1 |
| Bodey, GP; Freireich, EJ; Hart, J; Rodriguez, V | 1 |
| Benoy, CJ; Elson, LA; Schneider, R | 1 |
| Das, L; Dohlwitz, A; Hall, TC; Jaffe, N; Moloney, WC; Traggis, DG | 1 |
| Buchanan, JG | 1 |
| Blom, J; Burningham, R; Cuttner, J; Falkson, G; Glidewell, O; Holland, JF; Levy, RN; Moon, JH; Onuma, T; Rosner, F; Silver, RT | 1 |
| Goldenberg, DM; Witte, S | 1 |
2 review(s) available for cytarabine and Emesis
| Article | Year |
|---|---|
Advances in the management of nausea and vomiting induced by non-cisplatin containing chemotherapeutic regimens.
Topics: Adrenal Cortex Hormones; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzodiazepines; Cannabinoids; Cytarabine; Dopamine Antagonists; Humans; Metoclopramide; Nausea; Phenothiazines; Serotonin Antagonists; Vomiting | 1989 |
The intracavitary administration of cytarabine to patients with nonhematopoietic malignancies: pharmacologic rationale and results of clinical trials.
Topics: Abdomen; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Cisplatin; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation; Female; Humans; Kidney Diseases; Kinetics; Leukopenia; Nausea; Neoplasms; Ovarian Neoplasms; Pain; Peritoneal Cavity; Peritonitis; Pleura; Thrombocytopenia; Vomiting | 1985 |
35 trial(s) available for cytarabine and Emesis
| Article | Year |
|---|---|
Every-other-day palonosetron plus aprepitant for prevention of emesis following induction chemotherapy for acute myeloid leukemia: A randomized, controlled study from the "Rete Ematologica Pugliese".
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Cytarabine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Palonosetron; Treatment Failure; Vomiting; Young Adult | 2020 |
Single daily dosing versus divided dosing intravenous ondansetron to prevent chemotherapy-induced nausea and vomiting among children: A comparative randomized double-blind controlled trial.
Topics: Adolescent; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Double-Blind Method; Female; Hematologic Neoplasms; Humans; Hydrocortisone; Infant; Infant, Newborn; Male; Methotrexate; Nausea; Ondansetron; Prospective Studies; Vomiting | 2021 |
Randomized, Placebo-Controlled, Phase III Trial of Fosaprepitant, Ondansetron, Dexamethasone (FOND) Versus FOND Plus Olanzapine (FOND-O) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Hig
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Male; Melphalan; Middle Aged; Morpholines; Nausea; Olanzapine; Ondansetron; Podophyllotoxin; Vomiting | 2018 |
Combination of vorinostat and low dose cytarabine for patients with azacitidine-refractory/relapsed high risk myelodysplastic syndromes.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Hydroxamic Acids; In Vitro Techniques; Middle Aged; Myelodysplastic Syndromes; Nausea; Neutropenia; Recurrence; Risk Factors; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vomiting; Vorinostat | 2014 |
Phase II, open label, randomized comparative trial of ondansetron alone versus the combination of ondansetron and aprepitant for the prevention of nausea and vomiting in patients with hematologic malignancies receiving regimens containing high-dose cytara
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Cytarabine; Dose-Response Relationship, Drug; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Morpholines; Nausea; Ondansetron; Treatment Outcome; Vomiting | 2015 |
Daily palonosetron is superior to ondansetron in the prevention of delayed chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Female; Humans; Isoquinolines; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Ondansetron; Palonosetron; Quinuclidines; Serotonin Antagonists; Vomiting | 2010 |
A triple-drug combination to prevent nausea and vomiting following BEAM chemotherapy before autologous hematopoietic stem cell transplantation.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Carmustine; Cytarabine; Dexamethasone; Drug Therapy, Combination; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Isoquinolines; Lymphoma, Non-Hodgkin; Male; Melphalan; Morpholines; Nausea; Ondansetron; Palonosetron; Quinuclidines; Transplantation, Autologous; Treatment Outcome; Vomiting | 2011 |
Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cytarabine; Drug Administration Schedule; Fatigue; Female; Humans; Kaplan-Meier Estimate; Leukopenia; Lymphoma, Mantle-Cell; Male; Middle Aged; Nausea; Neutropenia; Nitrogen Mustard Compounds; Positron-Emission Tomography; Remission Induction; Rituximab; Transplantation, Autologous; Treatment Outcome; Vomiting | 2013 |
Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow
Topics: Adolescent; Adult; Age Factors; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Child; Cytarabine; Disease-Free Survival; Female; Follow-Up Studies; Hemorrhage; Humans; Idarubicin; Infections; Leukemia, Promyelocytic, Acute; Leukocyte Count; Male; Mercaptopurine; Methotrexate; Middle Aged; Remission Induction; Treatment Outcome; Vomiting | 2002 |
[Preliminary study on DHAP regimen for patients with relapsed and refractory non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Cytarabine; Dexamethasone; Female; Fever; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Survival Rate; Treatment Outcome; Vomiting | 2002 |
Intensive cytosine arabinoside therapy in small cell carcinoma of the lung.
Topics: Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Infusions, Parenteral; Lung Neoplasms; Male; Middle Aged; Nausea; Thrombocytopenia; Vincristine; Vomiting | 1984 |
Randomized trial of cyclophosphamide, doxorubicin, and 5-fluorouracil alone or alternating with a "cycle active" non-cross-resistant combination in women with visceral metastatic breast cancer: a Southeastern Cancer Study Group project.
Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Drug Resistance; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Methotrexate; Nausea; Random Allocation; Thrombocytopenia; Vincristine; Vomiting | 1984 |
Chlorpromazine with and without lorazepam as antiemetic therapy in children receiving uniform chemotherapy.
Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chlorpromazine; Cytarabine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infant; Lorazepam; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Teniposide; Vomiting | 1993 |
[Study on the inhibitory effect of oral granisetron against nausea/vomiting induced by cytosine arabinoside containing chemotherapy for tumors in the hematopoietic organs].
Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Granisetron; Humans; Indazoles; Lymphoma; Male; Middle Aged; Mitoxantrone; Nausea; Vomiting | 1993 |
Chemotherapy induced nausea and emesis in pediatric cancer patients: external validity of child and parent emesis ratings.
Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Attitude; Child; Child, Preschool; Cytarabine; Double-Blind Method; Female; Humans; Infant; Male; Nausea; Parents; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Severity of Illness Index; Sick Role; Teniposide; Vomiting | 1993 |
Comparison of efficacies of ondansetron and dixyrazine for prophylaxis of emesis during induction treatment in acute myelogenous leukemia. A pilot study.
Topics: Adult; Aged; Aged, 80 and over; Amsacrine; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Ondansetron; Phenothiazines; Pilot Projects; Serotonin Antagonists; Vomiting | 1997 |
Idarubicin and intermediate dose ARA-C followed by consolidation chemotherapy or bone marrow transplantation in relapsed or refractory acute myeloid leukemia.
Topics: Acute Disease; Adult; Agranulocytosis; Antibiotics, Antineoplastic; Bone Marrow Transplantation; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Idarubicin; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Nausea; Remission Induction; Thrombocytopenia; Treatment Outcome; Vomiting | 1997 |
Navoban (tropisetron, ICS 205-930) and dexamethasone combination in the prevention of vomiting for patients receiving preconditioning high-dose chemotherapy before marrow transplantation.
Topics: Adolescent; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Carmustine; Child; Cyclophosphamide; Cytarabine; Dexamethasone; Dizziness; Drug Therapy, Combination; Female; Headache; Heartburn; Humans; Indoles; Leukemia; Male; Melphalan; Middle Aged; Multiple Myeloma; Podophyllotoxin; Transplantation Conditioning; Tropisetron; Vomiting; Whole-Body Irradiation | 1998 |
Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Cytarabine; Diarrhea; Distamycins; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Leukemia; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Mice; Mice, SCID; Middle Aged; Nausea; Nitrogen Mustard Compounds; Transplantation, Heterologous; Tumor Cells, Cultured; Vomiting | 1997 |
[Efficacy of granisetron in the prevention of emesis induced by conditioning chemotherapy for allogeneic bone marrow transplantation].
Topics: Adolescent; Adult; Antiemetics; Bone Marrow Transplantation; Cyclophosphamide; Cytarabine; Female; Granisetron; Hematologic Neoplasms; Humans; Male; Middle Aged; Transplantation Conditioning; Vomiting; Whole-Body Irradiation | 1998 |
[A phase II study with high-dose cytarabine (NS-075) in adult patients with relapsed and refractory acute leukemia].
Topics: Adolescent; Adult; Aged; Anorexia; Antimetabolites, Antineoplastic; Cytarabine; Diarrhea; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vomiting | 1998 |
Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Granisetron; Hematopoietic Stem Cell Transplantation; Humans; Indoles; Lymphoma; Male; Melphalan; Nausea; Ondansetron; Serotonin Antagonists; Transplantation, Autologous; Tropisetron; Vomiting | 2000 |
Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Arachnoiditis; Breast Neoplasms; Cohort Studies; Cytarabine; Delayed-Action Preparations; Female; Headache; Humans; Injections, Spinal; Meningeal Neoplasms; Middle Aged; Nausea; Survival Analysis; Treatment Outcome; Treatment Refusal; Vomiting | 2001 |
Randomized, double-blind, crossover, placebo-controlled trial of intravenous ondansetron for the prevention of intrathecal chemotherapy-induced vomiting in children.
Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cross-Over Studies; Cytarabine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Humans; Hydrocortisone; Injections, Intravenous; Leukemia; Male; Mercaptopurine; Methotrexate; Nausea; Ondansetron; Risk; Serotonin Antagonists; Treatment Outcome; Vincristine; Vomiting | 2001 |
L-asparaginase and prednisolone pretreatment followed by rubidomycin and cytosine arabinoside for induction of remission in adult patients with acute myeloblastic leukaemia.
Topics: Adolescent; Adult; Age Factors; Aged; Asparaginase; Cytarabine; Daunorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Nausea; Prednisolone; Remission, Spontaneous; Vomiting | 1975 |
Prevention of cyclophosphamide/cytarabine-induced emesis with ondansetron in children with leukemia.
Topics: Administration, Oral; Adolescent; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Drug Evaluation; Female; Humans; Imidazoles; Injections, Intravenous; Liver Function Tests; Male; Ondansetron; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Serotonin Antagonists; Vomiting | 1990 |
Toxicity of high-dose cytosine arabinoside in the treatment of advanced childhood tumors resistant to conventional therapy. A Pediatric Oncology Group study.
Topics: Child; Cytarabine; Drug Administration Schedule; Fibrosarcoma; Humans; Infusions, Intravenous; Nausea; Neoplasms; Neuroblastoma; Pilot Projects; Rhabdomyosarcoma; Vomiting | 1990 |
Ip chemotherapy employing a regimen of cisplatin, cytarabine, and bleomycin.
Topics: Abdominal Neoplasms; Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Catheters, Indwelling; Cisplatin; Clinical Trials as Topic; Cytarabine; Drug Administration Schedule; Female; Humans; Injections, Intraperitoneal; Laparotomy; Male; Middle Aged; Ovarian Neoplasms; Pain; Peritoneal Cavity; Solutions; Vomiting | 1986 |
2'-Fluoro-5-iodoarabinosylcytosine, a new potent antiviral agent: efficacy in immunosuppressed individuals with herpes zoster.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Chemical Phenomena; Chemistry; Child; Clinical Trials as Topic; Cytarabine; Double-Blind Method; Female; Herpes Zoster; Humans; Immune Tolerance; Male; Middle Aged; Nausea; Neoplasms; Random Allocation; Vidarabine; Vomiting | 1986 |
Antiemetic therapy in patients treated with high-dose cytosine arabinoside.
Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Clinical Trials as Topic; Cytarabine; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Metoclopramide; Middle Aged; Nausea; Time Factors; Vomiting | 1987 |
Sequential studies on the role of mitoxantrone in the treatment of acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Agranulocytosis; Anthraquinones; Antineoplastic Agents; Bone Marrow Transplantation; Clinical Trials as Topic; Cytarabine; Female; Heart; Humans; Leukemia; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Nausea; Stroke Volume; Vomiting | 1985 |
Chemotherapy of acute leukemia. Comparison of cytarabine alone and in combination with vincristine, prednisone, and cyclophosphamide.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Anemia; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocyte Count; Leukopenia; Male; Middle Aged; Nausea; Prednisone; Time Factors; Vincristine; Vomiting | 1974 |
Comparison of treatment of metastatic gastrointestinal cancer with 5-fluorouracil (5-FU) to a combination of 5-FU with cytosine arabinoside.
Topics: Adenocarcinoma; Clinical Trials as Topic; Colonic Neoplasms; Cytarabine; Diabetic Ketoacidosis; Diarrhea; Drug Combinations; Evaluation Studies as Topic; Fluorouracil; Gastrointestinal Neoplasms; Humans; Leukopenia; Placebos; Stomach Neoplasms; Thrombocytopenia; Vomiting | 1972 |
Combination chemotherapy using L-asparaginase, daunorubicin, and cytosine arabinoside in adults with acute myelogenous leukaemia.
Topics: Adolescent; Adult; Aged; Asparaginase; Blood Cell Count; Clinical Trials as Topic; Cytarabine; Daunorubicin; Edema; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Serum Albumin; Vomiting | 1970 |
Therapy of acute leukemia with the combination of cytosine arabinoside (NSC-63878) and cyclophosphamide (NSC-26271).
Topics: Acute Disease; Adolescent; Adult; Aged; Alanine Transaminase; Alopecia; Aspartate Aminotransferases; Bone Marrow Diseases; Child; Clinical Trials as Topic; Cyclophosphamide; Cystitis; Cytarabine; Drug Combinations; Evaluation Studies as Topic; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Nausea; Remission, Spontaneous; Vomiting | 1970 |
38 other study(ies) available for cytarabine and Emesis
| Article | Year |
|---|---|
The nutritional impact of CD19-targeted CAR-T therapy versus BEAM chemotherapy for adult patients with lymphoma.
Topics: Adult; Antigens, CD19; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Humans; Immunotherapy, Adoptive; Lymphoma; Mucositis; Nausea; Neoplasm Recurrence, Local; Receptors, Chimeric Antigen; Vomiting; Weight Loss | 2023 |
Analysis of treatment outcomes of intraventricular chemotherapy in 105 patients for leptomeningeal carcinomatosis from non-small-cell lung cancer.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cranial Nerve Diseases; Cytarabine; Erlotinib Hydrochloride; Female; Gefitinib; Headache; Humans; Hydrocortisone; Infusions, Intraventricular; Intracranial Pressure; Karnofsky Performance Status; Lung Neoplasms; Male; Meningeal Carcinomatosis; Mental Disorders; Methotrexate; Middle Aged; Nausea; Palliative Care; Protein Kinase Inhibitors; Quinazolines; Retrospective Studies; Vomiting | 2013 |
Association of ABCB1 polymorphisms with the efficacy of ondansetron in chemotherapy-induced nausea and vomiting.
Topics: Adolescent; Adult; Alleles; Antiemetics; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; Cytarabine; Cytochrome P-450 CYP2D6; Drug Resistance; Female; Haplotypes; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Ondansetron; Polymorphism, Single Nucleotide; Vomiting; Young Adult | 2014 |
Fosaprepitant for the prevention of nausea and vomiting in patients receiving BEAM or high-dose melphalan before autologous hematopoietic stem cell transplant.
Topics: Aged; Antiemetics; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cohort Studies; Cytarabine; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Middle Aged; Morpholines; Nausea; Podophyllotoxin; Prospective Studies; Retrospective Studies; Transplantation Conditioning; Vomiting | 2016 |
Evaluation of standardized triple intrathecal therapy toxicity in oncohematological pediatric patients.
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cohort Studies; Cytarabine; Female; Headache; Hematologic Neoplasms; Humans; Injections, Spinal; Male; Methotrexate; Prospective Studies; Vomiting | 2017 |
LACE-conditioned autologous stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma: treatment outcome and risk factor analysis from a single centre.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Diarrhea; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Recurrence; Stomatitis; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vomiting; Young Adult | 2011 |
[Efficacy of granisetron for preventing chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia treated with a combination of anthracycline and cytarabine].
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Constipation; Cytarabine; Female; Granisetron; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Retrospective Studies; Vomiting; Young Adult | 2012 |
Benign intracranial hypertension in association with acute lymphoblastic leukemia.
Topics: Acetazolamide; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chlorthalidone; Cyclophosphamide; Cytarabine; Daunorubicin; Diagnosis, Differential; Headache; Humans; Intracranial Hypertension; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Sinus Thrombosis, Intracranial; Vincristine; Vomiting | 2003 |
Anhydro-ara-5-fluorocytidine (AAFC) in gastrointestinal cancer. A phase II study.
Topics: Ancitabine; Antineoplastic Agents; Cytarabine; Drug Evaluation; Female; Gastrointestinal Neoplasms; Humans; Leukopenia; Male; Nausea; Vomiting | 1980 |
High-dose cytosine arabinoside and m-AMSA is effective therapy in relapsed acute nonlymphocytic leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Aminoacridines; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Drug Eruptions; Hemorrhage; Humans; Leukemia; Middle Aged; Nausea; Recurrence; Vomiting | 1984 |
High-dose cytarabine in acute leukemia: toxicity and pharmacokinetics.
Topics: Acute Disease; Adolescent; Adult; Cytarabine; Cytidine Deaminase; Female; Half-Life; Humans; Kinetics; Leukemia; Leukocyte Count; Male; Middle Aged; Nausea; Nucleoside Deaminases; Vomiting | 1983 |
Acute pancreatitis in association with cytosine arabinoside therapy.
Topics: Acute Disease; Adolescent; Anorexia; Asparaginase; Cytarabine; Humans; Leukemia, Lymphoid; Male; Pain; Pancreatitis; Time Factors; Ultrasonography; Vomiting | 1982 |
Assessment of chemotherapy-induced emesis and evaluation of a reduced-dose intravenous ondansetron regimen in pediatric outpatients with leukemia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Etoposide; Female; Humans; Infusions, Intravenous; Male; Nausea; Ondansetron; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Severity of Illness Index; Vomiting | 1995 |
FLAG (fludarabine, cytosine arabinoside, G-CSF) for refractory and relapsed acute myeloid leukemia.
Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Central Nervous System Diseases; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid; Male; Middle Aged; Nausea; Neutropenia; Treatment Outcome; Vidarabine; Vomiting | 1996 |
Downbeat nystagmus caused by thiamine deficiency: an unusual presentation of CNS localization of large cell anaplastic CD 30-positive non-Hodgkin's lymphoma.
Topics: Adult; Anisocoria; Antineoplastic Combined Chemotherapy Protocols; Aphasia; Bleomycin; Brain Neoplasms; Cyclophosphamide; Cytarabine; Dizziness; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hemiplegia; Humans; Lymphoma, Large-Cell, Anaplastic; Methotrexate; Mitoxantrone; Neoplastic Stem Cells; Nystagmus, Pathologic; Prednisone; Remission Induction; Thiamine; Vincristine; Vomiting; Wernicke Encephalopathy | 1999 |
Safety and efficacy of a continuous infusion, patient controlled anti-emetic pump to facilitate outpatient administration of high-dose chemotherapy.
Topics: Adult; Ambulatory Care; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Dexamethasone; Diphenhydramine; Etoposide; Evaluation Studies as Topic; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Infusion Pumps; Infusions, Intravenous; Lorazepam; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Nausea; Patient Acceptance of Health Care; Prospective Studies; Safety; Self Care; Thiotepa; Vomiting | 1999 |
Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Disease Progression; Etoposide; Fatal Outcome; Female; Headache; Humans; Immunologic Factors; Injections, Spinal; Interferon alpha-2; Interferon-alpha; Mast-Cell Sarcoma; Nausea; Neoplasm Recurrence, Local; Palliative Care; Papilledema; Parietal Lobe; Prednisolone; Radioisotope Teletherapy; Recombinant Proteins; Remission Induction; Supratentorial Neoplasms; Temporal Lobe; Treatment Failure; Vomiting | 2001 |
Combination radiotherapy and chemotherapy for small cell carcinoma of the lung.
Topics: Alopecia; Antineoplastic Agents; Arrhythmias, Cardiac; Carcinoma, Small Cell; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Humans; Leukopenia; Lung Neoplasms; Methotrexate; Middle Aged; Vomiting | 1979 |
A phase II trial of high-dose cytarabine and cisplatin in previously untreated non-small cell carcinoma of the lung. A Piedmont Oncology Association Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cytarabine; Drug Evaluation; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Remission Induction; Vomiting | 1990 |
Treatment of refractory acute lymphoblastic leukemia in adults with high dose cytosine arabinoside and mitoxantrone (HAM).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Diarrhea; Drug Evaluation; Female; Humans; Male; Middle Aged; Mitoxantrone; Nausea; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Vomiting | 1990 |
Combined medical and psychological treatment of postchemotherapy nausea and vomiting: a case study.
Topics: Acute Disease; Behavior Therapy; Combined Modality Therapy; Cytarabine; Diazepam; Flurazepam; Humans; Leukemia; Male; Middle Aged; Nausea; Vomiting | 1989 |
A phase I-II study of cytosine arabinoside, daunorubicin, and VP16-213 in adult patients with acute non-lymphocytic leukemia.
Topics: Acute Disease; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Evaluation; Etoposide; Female; Humans; Leukemia; Male; Middle Aged; Nausea; Stomatitis; Vomiting | 1986 |
Mitoxantrone and ara-C in previously treated patients with acute myelogenous leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Diarrhea; Drug Administration Schedule; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Nausea; Vomiting | 1987 |
Toxicity evaluation of dihydroxyanthracenedione (DHAD) in combination with cytosine arabinoside (Ara-C).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Heart Diseases; Humans; Infant; Infusions, Intravenous; Leukemia, Lymphoid; Leukemia, Myeloid; Mitoxantrone; Nausea; Pancytopenia; Vomiting | 1987 |
Intermediate and high-dose ARA-C and m-AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukaemia and lymphoblastic non-Hodgkin lymphoma.
Topics: Adolescent; Adult; Aminoacridines; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Fever; Humans; Intercalating Agents; Intestinal Obstruction; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Middle Aged; Nausea; Time Factors; Vomiting | 1985 |
High-dose cytosine arabinoside in the treatment of childhood malignancies.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; Child; Child, Preschool; Cytarabine; Diterpenes; Doxorubicin; Female; Humans; Infant; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Male; Pancytopenia; Recurrence; Retinyl Esters; Vitamin A; Vomiting | 1985 |
[Non-hematologic toxicity in high-dose cytarabine therapy].
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Cytarabine; Dose-Response Relationship, Drug; Humans; Keratitis; Leukemia; Skin Diseases; Vomiting | 1985 |
Treatment of central nervous system leukemia with intrathecal cytosine arabinoside.
Topics: Adolescent; Adult; Animals; Brain Neoplasms; Child; Child, Preschool; Cytarabine; Dogs; Female; Haplorhini; Headache; Humans; Injections, Spinal; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Meninges; Middle Aged; Vomiting | 1973 |
Experimental use of cytosine arabinoside in congenital cytomegalovirus infection.
Topics: Agranulocytosis; Cytarabine; Cytomegalovirus; Cytomegalovirus Infections; Female; Humans; Infant; Infant, Newborn; Male; Thrombocytopenia; Vomiting | 1972 |
Cytosine arabinoside (NSC 63878) toxicity and antitumor acitivity in human solid tumors.
Topics: Adenocarcinoma; Anemia; Blood Cell Count; Blood Platelets; Bone Neoplasms; Breast Neoplasms; Cytarabine; Dose-Response Relationship, Drug; Female; Gastrointestinal Neoplasms; Hemoglobinometry; Humans; Injections, Intravenous; Leukopenia; Male; Nausea; Sarcoma; Thrombocytopenia; Vomiting | 1974 |
Combination chemotherapy of adult acute nonlymphoblastic leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Bone Marrow; Cytarabine; Drug Synergism; Female; Humans; Hydroxyurea; Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Remission, Spontaneous; Thioguanine; Vomiting | 1972 |
Cytosine arabinoside as a single agent in the therapy of adult acute leukemia.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Anemia; Child; Cytarabine; DNA, Neoplasm; Female; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Leukocytes; Male; Middle Aged; Muramidase; Nausea; Remission, Spontaneous; Sex Factors; Thioguanine; Thrombocytopenia; Time Factors; Vomiting | 1974 |
1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given alone and combined with antimetabolites in the treatment of advanced solid tumors.
Topics: Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Cystadenoma; Cytarabine; Female; Humans; Leukopenia; Lung Neoplasms; Male; Methotrexate; Nausea; Neoplasm Metastasis; Neoplasms; Nitrosourea Compounds; Ovarian Neoplasms; Stomach Neoplasms; Vomiting | 1972 |
Multiple emulsions, a suitable vehicle to provide sustained release of cancer chemotherapeutic agents.
Topics: Animals; Antineoplastic Agents; Cytarabine; Delayed-Action Preparations; Diarrhea; Emulsions; Lymphoma; Methotrexate; Mice; Neoplasms, Experimental; Pharmaceutical Vehicles; Rats; Vinblastine; Vomiting | 1972 |
Cytosine arabinoside in acute leukemia of childhood.
Topics: Child; Cytarabine; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukopenia; Remission, Spontaneous; Thrombocytopenia; Vomiting | 1971 |
Cytosine arabinoside therapy for acute myeloid leukaemia in adults.
Topics: Abdomen; Adolescent; Adult; Aged; Alopecia; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Cytarabine; Diarrhea; Erythrocytes; Female; Fever; Humans; Infusions, Parenteral; Injections, Intravenous; Kidney Diseases; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Ulcer; Vomiting | 1971 |
Treatment of adult leukemia with L-asparaginase (NSC-109229).
Topics: Adolescent; Adult; Aged; Allopurinol; Anaphylaxis; Asparaginase; Blood Coagulation Disorders; Cytarabine; Daunorubicin; Drug Hypersensitivity; Female; Fever; Gastrointestinal Hemorrhage; Hallucinations; Humans; Hyperglycemia; Injections, Intravenous; Jaundice; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Liver; Male; Mercaptopurine; Methotrexate; Middle Aged; Oral Hemorrhage; Prednisone; Thioguanine; Uremia; Vincristine; Vomiting | 1971 |
The treatment of polycythemia vera with cytosine arabinoside.
Topics: Adult; Aged; Cytarabine; Humans; Middle Aged; Nausea; Polycythemia Vera; Vomiting | 1967 |